Clinical Trial Update: Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how anti-epileptic drugs influence the pharmacokinetics of the etonogestrel-releasing implant in women with epilepsy has been suspended…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Antiepileptic drugs
• Nexplanon (etonogestrel implant)

Snippet

Sponsor: University of Sao Paulo | Conditions: Contraception, Drug Interactions | Phase 4 | Status: SUSPENDED